Agnieszka Mieszkowska-Dansonka

Gliwice Branch
Gliwice, SL, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications
Published: September 09, 2025

High Frequency of PIK3R1 Alterations in Ovarian Cancers: Clinicopathological and Molecular Associations.

High Frequency of PIK3R1 Alterations in Ovarian Cancers: Clinicopathological and Molecular Associations.

Journal: Cancers
Published: November 22, 2024

The Diversity of Methylation Patterns in Serous Borderline Ovarian Tumors and Serous Ovarian Carcinomas.

The Diversity of Methylation Patterns in Serous Borderline Ovarian Tumors and Serous Ovarian Carcinomas.

Journal: Cancers
Published: September 07, 2024

An Analysis of Genetic Polymorphisms in 76 Genes Related to the Development of Ovarian Tumors of Different Aggressiveness.

An Analysis of Genetic Polymorphisms in 76 Genes Related to the Development of Ovarian Tumors of Different Aggressiveness.

Journal: International journal of molecular sciences
Published: July 30, 2024

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Journal: medRxiv : the preprint server for health sciences
Published: March 18, 2024

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Journal: NPJ genomic medicine
Published: March 14, 2024

PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.

PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.

Journal: PloS one
Published: December 02, 2021

The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.

The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.

Journal: Pathology, research and practice
Published: May 28, 2021

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.

Journal: Cancer biology & therapy
Published: March 02, 2019

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.

Journal: PloS one
Published: October 31, 2017

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Journal: British journal of cancer
Published: August 08, 2017

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

Journal: Oncotarget
Published: March 31, 2017
Showing 1-12 of 52

Last Updated: 09/26/2026